GLP-1 For Weight Loss: Experts Reveal The Truth Behind The Popular Metabolic Drugs

Last Updated:March 06, 2026, 10:28 IST

GLP-1 weight loss drugs are trending worldwide. Doctors explain how they work, who should take them, and the benefits and risks of these metabolic medications.

GLP-1 weight-loss drugs like Mounjaro and semaglutide are booming, but experts continue to stress on lifestyle changes for lasting results. (Image: Getty)

Over the past few years, GLP-1 medications have rapidly gained attention as one of the most talked-about weight management treatments worldwide. Popularised on social media as ‘weight-loss injections,’ these drugs have sparked both curiosity and controversy. But beyond the headlines and celebrity buzz, doctors say GLP-1 receptor agonists are actually part of a broader medical approach to treating metabolic diseases such as obesity and type 2 diabetes.

Understanding how these medications work and who they are intended for is essential before considering them as part of a weight management strategy.

According to Dr Sanjay Agarwal, HOD, Obesity & Metabolic Diseases expert, Sahyadri Super Speciality Hospital, Pune, GLP-1 receptor agonists represent a significant advancement in obesity treatment. “Although they were originally developed for diabetes, these medications help control appetite by slowing gastric emptying and improving insulin response, allowing many people to achieve significant and sustained weight loss,” he explains.

Dr Sharad Sharma, Consultant – Laparoscopic & Bariatric Surgery, Fortis Hiranandani Hospital, Navi Mumbai, adds that their impact goes beyond weight alone. He explains, “GLP-1 analogues are metabolic drugs that modify clinically diagnosed diseases. While often popularised as weight-loss shots, medical guidelines emphasise that they are meant for chronic metabolic disease management.”

How GLP-1 Drugs Work In The Body

GLP-1 receptor agonists mimic a natural hormone that regulates appetite, insulin secretion, and digestion. By slowing gastric emptying and increasing feelings of fullness, they help reduce calorie intake.

Dr Sharma explains that these medications also act on the brain’s reward centres. He says, “They increase food satiety while improving pancreatic beta-cell response for better blood sugar control.” As a result, many patients experience improvements in metabolic markers alongside gradual weight loss.

Dr Agarwal highlights that the benefits extend beyond aesthetics. He adds, “Patients not only lose weight but also see improvements in obesity-related conditions such as type 2 diabetes, hypertension, fatty liver disease, sleep apnea and cardiovascular risk factors.”

Who Should Actually Use Them

Despite their growing popularity, GLP-1 drugs are not designed for casual or cosmetic weight loss. Dr Agarwal emphasises that these medications are recommended for individuals with clinically diagnosed obesity. He notes, “They are typically prescribed for patients with a BMI of 30 or higher, or those with a BMI of 27 and obesity-related conditions who have not achieved results through lifestyle changes alone.”

Dr Sharma adds that current global guidelines reinforce this medical framework. He says, “These drugs are primarily meant for metabolic disease treatment. Weight loss is often a secondary benefit rather than the primary objective.” He also notes that newer clinical data show additional health benefits. “Recent studies indicate these medications may reduce the risk of major cardiovascular events, even when weight loss is not the primary goal,” he adds.

Possible Side Effects And Risks

Like any prescription medication, GLP-1 therapies come with potential side effects and require careful monitoring.

Dr Agarwal says the most common issues are digestive. Nausea, vomiting, abdominal discomfort and constipation are the most frequently reported side effects. In rare cases, more serious complications such as pancreatitis or gallbladder disease can occur. Dr Sharma stresses that proper medical supervision is essential. Dose adjustments are often required to manage side effects, and patients must be monitored for metabolic changes and possible complications.

Why Lifestyle Still Matters

Experts say one of the biggest misconceptions about GLP-1 drugs is that they work independently of lifestyle habits. “These medications work best when combined with structured dietary changes, physical activity and behavioural support,” says Dr Agarwal. Obesity, he explains, is a chronic and relapsing disease that requires long-term management.

Dr Sharma also points out that discontinuing the medication without lifestyle changes can lead to weight regain. He says, “Clinical data suggests that patients may regain up to two-thirds of lost weight if the medication is stopped without permanent lifestyle integration.” He further notes that GLP-1 therapy is not a replacement for surgical options in severe obesity. He adds, “Bariatric surgery remains the most effective long-term treatment for morbid obesity in many cases.”

While GLP-1 medications have opened new possibilities in metabolic medicine, doctors emphasise that they are not quick fixes for weight loss. These therapies are designed to treat complex metabolic conditions and must be used under medical supervision alongside long-term lifestyle changes. As research continues to evolve, the focus is gradually shifting from rapid weight reduction to sustainable improvements in overall health and metabolic well-being.